Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma - Concepedia

Concepedia

Publication | Open Access

Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma

DOI Full Paper Access

56

Citations

28

References

2019

Year

Andrea Roderwieser, Frederik Sand, Esther Walter, J. Fischer, Judith Gecht, Christoph Bartenhagen, Sandra Ackermann, Felix Otte, Anne Welte, Yvonne Kahlert,

JCO Precision Oncology

Abstract

Our data suggest telomerase activation and ALT define distinct neuroblastoma subgroups with adverse outcome and that telomerase may represent a promising therapeutic target in many high-risk neuroblastomas.

References

	Year	Citations

Page 1